Global Melanoma Scanner Market Size, Trends, Share, Demand & Growth Opportunity Assessment, Regional Outlook, Industry Analysis, & Forecast 2017-2025

Global Melanoma Scanner Market 

Market Overview                            

Melanoma is aggressive and life-threatening and if left undetected, the prospects of recovery drop to less than 10%. Screening is complicated therefore, together with several project partners; researchers have developed an assistance system that helps dermatologists with diagnosis. Around 200,000 people contract skin cancer every year. Routine screening is the only way to detect critical skin changes at an early stage, in this doctor uses a dermatoscope to peers into the deeper layer of the skin to examine abnormal moles, called melanocytic nevus. Several novel, hand-held, automated optical scanning devices have been developed to aid care providers in early diagnosis and these technologies quickly and non-invasively permit visualization deeper into the skin to detect evidence of malignant change.

Goldstein Research analyst forecast the melanoma scanner market size is set to reach USD 850 million by 2025, at a CAGR of 7.6% over the forecast period. High investment by skin cancer diagnostic & therapeutic companies and increasing number of pipeline products for cancer diagnosis under clinical trials are the key factors which are driving the growth of market of melanoma scanners.

Intended Audience

• Melanoma Scanner Suppliers
• Melanoma Scanner Manufacturers
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Diagnostic Centers
• Business consultancies
• Venture capitalists
• Public and private health agencies

Covered In This Global Melanoma Scanner Market Report        

The report covers the present ground scenario and the future growth prospects of the melanoma scanner market for 2017-2025 along with the data of shipments of melanoma scanner worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The melanoma scanner market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Global Melanoma Scanner Market Segmentation

By Product Type

• Standalone Melanoma Scanner
• Handheld Melanoma Scanner

By Skin Melanoma

• Superficial Spreading Melanoma
• Nodular Melanoma
• Lentigo Maligna
• Acral Lentiginous Melanoma

By End User

• Hospitals
• Clinics
• Cancer Research Organizations

Based on Geography

• North America (U.S. & Canada)  Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest of Latin America)  Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE)  Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia)  Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA)  Melanoma Scanner Market {Market Share (%), Market Size (USD Billion)}

Based on product type, handheld melanoma scanner dominated the global melanoma scanner market and accounted for the market share of 65% in 2017 of total melanoma scanner market attributed to hand-held device are easy to learn and use, and it rapidly provides accurate images of the melanin, blood, and collagen below the mole or lesion. On the basis of the end user, Cancer Research Institutes & skin clinics tends to be the fastest growing segment due to the awareness and increasing prevalence of skin melanomas.

Global Melanoma Scanner Industry Trends, Demand & Challenges

Global Melanoma Scanner Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Melanoma Scanner market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global Melanoma Scanner market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our global melanoma scanner market report comprises of the following companies as the key players: Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca.

According to our global market study on the basis of extensive primary and secondary research: “One trend is the concept of “automated dermatologist” which detects skin cancer with expert accuracy and the objective is to bring the expertise of top-level dermatologists to places where the dermatologist is not available. In this, the research team employed a convolutional neural network, a type of computer software that is very good at learning to recognize different concepts. By downloading digital images, researchers can "tell" the computer they are images of skin cancer, or without skin cancer. The machine will basically try to learn some rules that can predict whether it's cancer.”

According to the report, major driving factor is the growing skin cancer therapeutics market with increasing prevalence of melanoma skin cancer cases. Melanomas represent fewer than 5% of all skin malignancies diagnosed in the US, yet they account for nearly three-quarters of all deaths related to this form of cancer. If detected early, the five-year survival rate for melanoma is 99%. When detected in its latest stage, the survival rate plummets to just 14%.   

Further, the report states the biggest challenge is unavailability of melanoma scanner and the trained staff in some of the emerging economies coupled with high treatment cost of melanoma skin cancer is restraining the growth of melanoma scanner market.  

Based on geography, North America is anticipated to dominate the global melanoma market due to increasing cases of melanoma. In Canada, melanoma is the seventh most common cancer, with about 6,000 new cases estimated in 2013 (3,300 men and 2,700 women) and an age-standardized incidence rate of 13.4 per 100,000 people (15.1 for men and 12.2 for women). Several non-invasive, automated, hand-held optical scanners have been developed to help dermatologists determine whether a skin biopsy is indicated is driving the melanoma scanner market in Europe and APAC regions.  

 The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Melanoma Scanner Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the revenue of total market in 2016-17 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.